Sunday, October 08, 2017 11:27:42 PM
This seems to be a good potential for a stock to go long - but I have some questions..Hopefully someone can shed some light.
1. From recent news, the company indicated that the recent stock issuance is to allow the Company to fund the "initiation of its Phase 3 clinical program" of RP-G28 for the treatment of lactose intolerance, expected to begin in the first half of 2018. --->The word "initiation" somehow really bothers me as it sounds like, there may be more coming. Can someone shed somelight on this?
2. Potential of >$1.2Billions of prescription market. Can someone translate tha to sales or perhaps potential sp?
3. Timeline of completion of P3 Trial?
Thanks
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM